Established in 2002, the Australasian Hepatology Association (AHA) is the peak professional body supporting and educating hepatology nurses and allied health professionals across Australia and New Zealand.  Our membership consists of well-informed forward-thinking and experienced Hepatology professionals who encompass many specialist areas in a variety of settings.

These include Hepatitis B and C treatment and care, chronic liver disease and chronic disease management, liver transplantation, liver cancer, health policy, sexual health, mental health, drug and alcohol, infectious diseases, indigenous health, culturally and linguistically diverse (CALD) health services, prison health services and nutrition.

The Australasian Hepatology Association remains at the forefront of healthcare and community education and is recognised worldwide as a leader in developing innovative resources, such as The Australasian Hepatology Association Consensus Based Nursing Guidelines for the Care of Patients with Hepatitis B, Hepatitis C, Advanced Liver Disease and Hepatocellular Carcinoma (2012).

Prevalence of Liver Disease in Australia report - The economic cost and health burden of liver disease in Australia, January 2013

Coming Events

View Calendar

AASLD: The Liver Meeting

13 November 2020 - 17 November 2020

The Liver MeetingĀ® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field.

Introduction to the Nursing Care and Management of Patients with Advanced Liver Disease - ONLINE VERSION

17 November 2020 - 01 December 2020
6.00pm AEDT - 7.30pm AEDT

** NOW AVAILABLE ONLINE ** Our aim is to educate registered nurses across primary and tertiary care about the specialised management of patients with cirrhosis of the liver. By sharing evidence-based protocols and guidelines, and using specific case studies, this course will give nurses the knowledge and confidence required to care for patients with advanced liver disease.

More Info Register Now

International Viral Hepatitis Elimination Meeting (IVHEM)

04 December 2020 - 05 December 2020

The 2020 program of IVHEM includes key practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment, all with a focus on meeting the 2030 elimination targets set by the World Health Organization (WHO). AHA members are entitled to a 25% discount on the registration fee.Ā 

More Info

Latest News

View News

Tracey Jones has been awarded the designation of Associate Fellow AASLD

18 August 2020

AHA Life Member & Justice Health and Forensic Mental Health Network (Network) Hepatology Nurse Practitioner, Tracey Jones, has become the first Australian nurse to be awarded the Associate Fellow - American Association for the Study of Liver Diseases designation. The award recognises clinical excellence and significant contribution to the field of liver disease.


World Hepatitis Days - 28 July 2020

03 August 2020

Worldwide, 290 million people are living with viral hepatitis unaware. Without finding the undiagnosed and linking them to care, millions will continue to suffer, and lives will be lost. On World Hepatitis Day, 28 July, we call on people from across the world to take action and raise awareness to find the 'missing millions'.


Why is my AHA membership important?

24 July 2020

Read the July 2020 update on the numerous projects and activities at AHA


Employment Ads

View Employment Ads

CNC Viral Hepatitis, NSP (Grade 2)

Applications close: 29 October 2020

WSLHD is recruiting a CNC Viral Hepatitis, NSP (Grade 2). The key focus of this new role is to improve viral hepatitis testing and increase treatment rates in primary NSPs across WSLHD.